glp 1 bmi and GLP-1 Weight Loss Treatment: What BMI Qualifies? What BMI Do You Need

Cedars-Sinai experts explain what microdosing means, its potential benefits and risks, and what patients should know before trying it.

Limited data are available on the risk of pancreatic adverse events among people with obesity or type 2 diabetes mellitus (T2DM) initiating glucagon-like peptide-1 receptor agonist (GLP-1 RA)

Rapid fat loss can reduce facial volume, affect skin elasticity, and increase hair shedding

In this Huberman Lab episode, my guest is Zachary Knight, Ph.D., a professor of physiology at the University of California, San Francisco (UCSF), and Howard Hughes Medical Institute (HHMI) investigator.